Impacto cardiovascular secundario a la terapia para el control del cáncer

Cardiovascular diseases and cancer account for 27 and 25% of mortality in Chile, respectively. In the last decades, survival of people with cancer has improved due to preventive programs, early detection strategies, advances in technology and development of new antineoplastic therapies. Consequently...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ríos,Juvenal A., Rojo,Pamela, Schuster,AndréS, Gormaz,Juan G., Carrasco,Rodrigo, Neira,Carolina, Becerra,Sergio, Labbé,Tomas P.
Lenguaje:	Spanish / Castilian
Publicado:	Sociedad Médica de Santiago 2020
Materias:	Anthracyclines Cardiotoxicity Drug Therapy Neoplasms
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000100093
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:scielo:S0034-98872020000100093
record_format	dspace
spelling	oai:scielo:S0034-988720200001000932020-04-02Impacto cardiovascular secundario a la terapia para el control del cáncerRíos,Juvenal A.Rojo,PamelaSchuster,AndréSGormaz,Juan G.Carrasco,RodrigoNeira,CarolinaBecerra,SergioLabbé,Tomas P. Anthracyclines Cardiotoxicity Drug Therapy Neoplasms Cardiovascular diseases and cancer account for 27 and 25% of mortality in Chile, respectively. In the last decades, survival of people with cancer has improved due to preventive programs, early detection strategies, advances in technology and development of new antineoplastic therapies. Consequently, a progressive number of cancer-surviving patients have been generated, who may develop cardiovascular diseases, secondary to the same cancer therapy. Cardio-Oncology has emerged as the necessary link between both specialties to promote the prevention and early detection of cardiac complications, in patients undergoing oncological therapies. The aim is to curb cardiovascular complications. Also, to acquire knowledge about the mechanisms and effects of drugs that lead to heart damage aiming to develop efficient cardioprotective therapies. In this article we review and propose a didactic organization and classification of the main cardiovascular effects of cancer control therapy. We recognize that there is still a knowledge gap in basic sciences about the mechanisms that underlie these alterations.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.148 n.1 20202020-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000100093es10.4067/S0034-98872020000100093
institution	Scielo Chile
collection	Scielo Chile
language	Spanish / Castilian
topic	Anthracyclines Cardiotoxicity Drug Therapy Neoplasms
spellingShingle	Anthracyclines Cardiotoxicity Drug Therapy Neoplasms Ríos,Juvenal A. Rojo,Pamela Schuster,AndréS Gormaz,Juan G. Carrasco,Rodrigo Neira,Carolina Becerra,Sergio Labbé,Tomas P. Impacto cardiovascular secundario a la terapia para el control del cáncer
description	Cardiovascular diseases and cancer account for 27 and 25% of mortality in Chile, respectively. In the last decades, survival of people with cancer has improved due to preventive programs, early detection strategies, advances in technology and development of new antineoplastic therapies. Consequently, a progressive number of cancer-surviving patients have been generated, who may develop cardiovascular diseases, secondary to the same cancer therapy. Cardio-Oncology has emerged as the necessary link between both specialties to promote the prevention and early detection of cardiac complications, in patients undergoing oncological therapies. The aim is to curb cardiovascular complications. Also, to acquire knowledge about the mechanisms and effects of drugs that lead to heart damage aiming to develop efficient cardioprotective therapies. In this article we review and propose a didactic organization and classification of the main cardiovascular effects of cancer control therapy. We recognize that there is still a knowledge gap in basic sciences about the mechanisms that underlie these alterations.
author	Ríos,Juvenal A. Rojo,Pamela Schuster,AndréS Gormaz,Juan G. Carrasco,Rodrigo Neira,Carolina Becerra,Sergio Labbé,Tomas P.
author_facet	Ríos,Juvenal A. Rojo,Pamela Schuster,AndréS Gormaz,Juan G. Carrasco,Rodrigo Neira,Carolina Becerra,Sergio Labbé,Tomas P.
author_sort	Ríos,Juvenal A.
title	Impacto cardiovascular secundario a la terapia para el control del cáncer
title_short	Impacto cardiovascular secundario a la terapia para el control del cáncer
title_full	Impacto cardiovascular secundario a la terapia para el control del cáncer
title_fullStr	Impacto cardiovascular secundario a la terapia para el control del cáncer
title_full_unstemmed	Impacto cardiovascular secundario a la terapia para el control del cáncer
title_sort	impacto cardiovascular secundario a la terapia para el control del cáncer
publisher	Sociedad Médica de Santiago
publishDate	2020
url	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872020000100093
work_keys_str_mv	AT riosjuvenala impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer AT rojopamela impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer AT schusterandres impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer AT gormazjuang impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer AT carrascorodrigo impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer AT neiracarolina impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer AT becerrasergio impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer AT labbetomasp impactocardiovascularsecundarioalaterapiaparaelcontroldelcancer
_version_	1718437105225433088

Impacto cardiovascular secundario a la terapia para el control del cáncer

Ejemplares similares